Raza H, Riaz M, Habiba UE, Mehboob Z. Clinical Outcomes of CRISPR-Cas9 Mediated Gene Editing in Patients with Sickle Cell Disease: A Biotechnology-Based Therapeutic Approach. IRABCS [Internet]. 2025 Jun. 30 [cited 2025 Aug. 31];3(1):15-21. Available from: https://irjpl.org/irabcs/article/view/126